Todd Brown, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Co-investigator

Email:

Tbrown27@jhmi.edu
  • Member, Bone Complications Working Group of the Inflammation TSG (Aug 2008 – Present)
  • Member, Immune Activation Focus Group of Inflammation TSG (Aug 2014-Present)
  • Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
  • Protocol Vice-Chair, ACTG 5280, ACTG 5303
  • Co-chair, ACTG 5361s
  • Co-investigator, ACTG 5257

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5207, Maintaining Options for Mothers Study (MOMS): A Phase...

A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...

Read More

P1060:  Phase II, parallel, randomized, clinical trials...

A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

A5314: Effect of LDMTX on Inflammation in HIV-infected...

A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...

Read More

A5332: Randomized Trial to Prevent Vascular Events in HIV...

REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....

Read More